Table 2 Comparison between the NSIP pattern group and UIP pattern group in clinical baseline characteristics.
Characteristic | NSIP (n = 133) | UIP (n = 51) | P value |
---|---|---|---|
Age (year) | 64.4 ± 13.5 | 70.0 ± 11.6 | 0.001 |
M/F | 38/95 | 27/24 | 0.002 |
Smoking | 26 (19.5%) | 21 (41.2%) | 0.003 |
Follow-up time, m | 42.0 [22.5–64.0] | 52.0 [35.0–74.0] | 0.012 |
Pulmonary function tests1 | |||
FEV1% predicted | 85.8 ± 21.7 | 78.3 ± 21.2 | 0.11 |
FVC% predicted | 81.3 ± 17.9 | 70.9 ± 20.8 | 0.011 |
FEV1/FVC Ratio | 86.3 ± 6.2 | 88.0 ± 8.9 | 0.27 |
DLCO% predicted | 63.5 ± 19.8 | 52.0 ± 20.5 | 0.012 |
ILD-GAP Index1 | |||
Stage I (0,1) | 62 (70.5%) | 7 (24.1%) | <0.001 |
Stage II (2,3) | 22 (25.0%) | 16 (55.2%) | 0.003 |
Stage III (4,5) | 4 (4.5%) | 3 (10.3%) | 0.25 |
Stage IV (>5) | 0 (0%) | 3 (10.3%) | 0.002 |
SPAP ≥ 37 mmHg | 27 (20.3%) | 19 (37.3%) | 0.017 |
Outcome | |||
Acute exacerbations of ILD | 18 (13.5%) | 14 (27.5%) | 0.026 |
Combined with lung cancer | 7 (5.3%) | 3 (5.9%) | 0.87 |
Death of all cause | 19 (14.3%) | 20 (39.2%) | <0.001 |